Consensus statement on depression, anxiety, and cardiovascular disease

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 8, 2001, Pages 24-27

  Ballenger, James C ^a   Davidson, Jonathan R T ^b   Lecrubier, Yves ^b   Nutt, David J ^b   Roose, Steven P ^b   Sheps, David S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

AGE; ANXIETY NEUROSIS; BEHAVIOR THERAPY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; HUMAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCREENING; TREATMENT PLANNING;

ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY DISORDERS; CARDIOVASCULAR DISEASES; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; PRACTICE GUIDELINES; PSYCHOTHERAPEUTIC PROCESSES; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 0035022563     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Wulsin L, Vaillant G, Wells V. A systematic review of the mortality of depression. Psychosom Med 1999;61:6-17
2. Aromaa A, Raitasalo R. Reunanen A, et al. Depression and cardiovascular diseases. Acta Psychiati Scand 1994;377:77-82
3. Carney RM, Rich MW, Tevelde A, et al. Major depressive disorder in coronary artery disease. Am J Cardiol 1987;60:1273-1275
4. Carney R, Rich MW, Freedland K, et al. Major depressive disorder predicts cardiac events in patients with coronary heart disease. Psychosom Med 1988;50:627-633
5. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149: 1785-1789
6. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1813-1825
7. Ladwig KH, Kieser M, Konig J, et al. Affective disorders and survival after acute myocardial infarction: results from the post-infarction late potential study. Eur Heart J 1991;12:959-964
8. Ladwig, KH, Roll G Breithardt G, et al. Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet 1994;343:20-23
9. Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998; 158:1422-1426
10. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996;93: 1976-1980
11. Kubansky L, Kawashi I, Weiss ST, et al. Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Am Behav Med 1998;20:47-58
12. Kawachi I, Colditz GA, Ascherio A, et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 1994;89: 1992-1997
13. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005
14. Wassertheil-Smoller S, Applegate WB, Berge K, et al. Change in depression as a precursor of cardiovascular events: SHEP Cooperative Research Group (Systolic Hypertension in the Elderly). Arch Intern Med 1996;156: 553-561
15. Penninx BW, Guralnik JM, Mendes de Leon CF, et al. Cardiovascular events and mortality in newly and chronically depressed persons > 70 years of age. Am J Cardiol 1998;81:988-994
16. Sheehan DV, Lecrubier Y, Janavs J, et al. Mini-International Neuropsychiatric Interview (MINI). Tampa, Fla: University of South Florida, Institute for Research in Psychiatry, and Paris. France: INSERM-Hôpital de la Salpêtrière; 1994
17. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA 1994;272:1749-1755
18. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370
19. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
20. Wells KB, Golding JM, Burnam MA. Psychiatric disorders in a sample of the general population with and without chronic medical conditions. Am J Psychiatry 1988;145:976-981
21. Lane D, Carroll D, Lip GY. Psychology in coronary care. Q J Med 1999; 92:425-431
22. Kannel WB, Kannel C, Paffenbarger RS Jr, et al. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-1494
23. Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406-412
24. Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med 1992;327:227-233
25. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 1998;279:287-291
26. Buselli FF, Stuart EM. Influence of psychosocial factors and biopsychosocial interaction on outcomes after myocardial infarction. J Cardiovasc Nurs 1999;13:60-72
27. Bennett P, Carroll D. Cognitive-behavioural intervention in cardiac rehabilitation. J Psychosum Res 1994;38:169-182